# Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis

> **NCT07678931** · PHASE3 · RECRUITING · sponsor: **Chengdu Kangnuoxing Biopharma,Inc.** · enrollment: 136 (estimated)

## Conditions studied

- Seasonal Allergic Rhinitis (SAR)

## Interventions

- **BIOLOGICAL:** Stapokibart
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT07678931
- **Lead sponsor:** Chengdu Kangnuoxing Biopharma,Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-08-13
- **Primary completion:** 2026-12
- **Final completion:** 2026-12
- **Target enrollment:** 136 (ESTIMATED)
- **Last updated:** 2026-09-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07678931

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07678931, "Study on the Treatment of Adolescent Patients With Seasonal Allergic Rhinitis". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07678931. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*